| Basics |
Mesoblast Limited
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
|
| IPO Date: |
October 10, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.29B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 2.47%
|
| Avg Daily Range (30 D): |
$0.22 | 1.39%
|
| Avg Daily Range (90 D): |
$0.21 | 1.33%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.14M |
| Avg Daily Volume (30 D): |
.16M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
141 |
| Avg Trade Size (Sh.) (30 D): |
58 |
| Avg Trade Size (Sh.) (90 D): |
68 |
| Institutional Trades |
| Total Inst.Trades: |
82 |
| Avg Inst. Trade: |
$1.51M |
| Avg Inst. Trade (30 D): |
$.76M |
| Avg Inst. Trade (90 D): |
$1.85M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.31M |
| Avg Closing Trade (30 D): |
$.76M |
| Avg Closing Trade (90 D): |
$2.15M |
| Avg Closing Volume: |
155.9K |
|
|
|
|
|
